A Study on the Anti-incontinent Effectiveness of the mTVM Method in POPQ Stage II-III Patients (TVMvsmTVM)
Primary Purpose
Uterine Prolapse, Urinary Stress Incontinence, Side Effects
Status
Unknown status
Phase
Not Applicable
Locations
Hungary
Study Type
Interventional
Intervention
Trans-vaginal Mesh operation
Sponsored by
About this trial
This is an interventional treatment trial for Uterine Prolapse
Eligibility Criteria
Inclusion Criteria:
- Coexisting SUI and POP Q St II-III and signature of the informed consent
Exclusion Criteria:
- Urge, mixed or neurogenic incontinency, occult SUI, previous mesh operations, antidepressive medical therapy, cancer of the pelvic organs, urinary infections, any sign of voiding difficulties
Sites / Locations
- Univ. of Szeged. Dep. of Obstetrics and GynaecologyRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Other
Other
Arm Label
Modified TVM operation
Control group
Arm Description
Modified Trans-vaginal Mesh operation (mTVM): polypropylene monofilament meshes produced by Aspide® fixed up to the mid urethra by a resolvable suture. 76 participants will be involved.
76 Participants as control group undergo a traditional Trans-vaginal Mesh operation (TVM) with polypropylene monofilament meshes produced by Aspide® . (Sergent et al.)
Outcomes
Primary Outcome Measures
Efficacy of the mTVM on genuine stress incontinence.
Measuring the anti incontinence effect of the used method by urodynamic examination anf pelvic floor sonography
Secondary Outcome Measures
Telorability of the mTVM method
Measuring the tolerability of the used method by the Clavien-Dindo classification system
Improvement in sexual life
Define the change in quality of sexual life after the used procedures by Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12)
Improvement in pelvic floor symphtoms
Define the change in quality of life after the used procedures by Pelvic Floor Distress Inventory (PFDI-20)
Improvement in quality of life
Define the change in quality of life after the used procedures by urogenital distress inventory (UDI-6)
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT02935803
Brief Title
A Study on the Anti-incontinent Effectiveness of the mTVM Method in POPQ Stage II-III Patients
Acronym
TVMvsmTVM
Official Title
A Prospective and Randomised Single Centre Study on the Anti-incontinent Effectiveness of the Modified Trans Vaginal Mesh Method in POPQ Stage II-III Patients
Study Type
Interventional
2. Study Status
Record Verification Date
October 2016
Overall Recruitment Status
Unknown status
Study Start Date
July 2016 (undefined)
Primary Completion Date
June 2017 (Anticipated)
Study Completion Date
June 2020 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Szeged University
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
An increasing number of specific procedures have been described for the surgical repair of pelvic organ prolapse (POP) and concomitant stress urinary incontinence (SUI). The investigators introduced an alternative operative method for POP-Q II-III repair and anti-incontinence with the trans vaginal mesh (TVM) anterior edge fixed to the periurethral tissues at the level of mid-urethra. The efficacy and short- and long-term complication profile, of this new surgical technique as compared with those of non-modified TVM.
Detailed Description
The prospective randomized double blind study comprised 152 women who presented for the correction of stress urinary incontinence (SUI) in conjunction with anterior compartment pelvic organ prolapse stage II-III (POP-Q II-III) at the Departments of Obstetrics and Gynecology at the University of Szeged, Hungary, between June of 2016 and June 2017. After a block randomization method, the patients will divide into two arms, the study group which consist of 76 patients will undergo modified trans vaginal mesh operation (TVM), the rest 76 patients as a control group will undergo a traditional TVM operation. Inclusion criteria in the study is coexisting SUI and POP Q St II-III and signature of the informed consent. The exclusion criteria are as follows: urge, mixed or neurogenic incontinence, occult SUI, previous mesh operations, anti-depressive medical therapy, cancer of the pelvic organs, urinary infections, any sign of voiding difficulties. The transobturator TVM operation (Sergent et al.) has been modofied by inserting a stabilizing suture, which fixing the anterior edge of the mesh to the para-urethral tissues at the level of the mid-urethra with two non-resolvable anchoring stitches thereby promoting the proper elevation and closure of the urethra. The hypothesis is the stabilizing suture treat the coexisting SUI as well. In all cases, urodynamic examinations were carried out before the surgery and urodynamic examinations comprising uroflowmetry, cystography and Valsalva leak point pressure tests and pelvic floor ultrasonography will be performed to determine the coexisting SUI. The efficacy of the POP repair is taken as a significant (>1 cm) improvement at points Aa, Ba, C and D according to the POP-Q system (International Continence Society) during the follow-up. The anti-incontinence efficacy is classified as no further SUI diagnosed by urodynamic examination and pelvic floor sonography. All patients will fill two validated Hungarian language questionnaires as "A short form of the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire" (PISQ-12) and "Pelvic Floor Distress Inventory" PFDI. After a one-year application phase all patients will be followed for 36 months. During follow- up phase repeated urodynamic studies, pelvic floor sonography urine culturing will be done after 3, 12, 24 and 36 months. The evaluation of the POP-Q system and Bonney's cough test and the PISQ-12 and PFDI questionnaires will be performed at every regular check-ups
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Uterine Prolapse, Urinary Stress Incontinence, Side Effects
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
76 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Modified TVM operation
Arm Type
Other
Arm Description
Modified Trans-vaginal Mesh operation (mTVM): polypropylene monofilament meshes produced by Aspide® fixed up to the mid urethra by a resolvable suture. 76 participants will be involved.
Arm Title
Control group
Arm Type
Other
Arm Description
76 Participants as control group undergo a traditional Trans-vaginal Mesh operation (TVM) with polypropylene monofilament meshes produced by Aspide® . (Sergent et al.)
Intervention Type
Procedure
Intervention Name(s)
Trans-vaginal Mesh operation
Intervention Description
Modified the transobturator TVM operation reported by Sergent et al. by inserting a stabilizing suture, which fixing the anterior edge of the mesh to the paraurethral tissues at the level of the mid-urethra with two non-resolvable anchoring stitches thereby promoting the proper elevation and closure of the urethra
Primary Outcome Measure Information:
Title
Efficacy of the mTVM on genuine stress incontinence.
Description
Measuring the anti incontinence effect of the used method by urodynamic examination anf pelvic floor sonography
Time Frame
36 months flollow up
Secondary Outcome Measure Information:
Title
Telorability of the mTVM method
Description
Measuring the tolerability of the used method by the Clavien-Dindo classification system
Time Frame
36 month follow up
Title
Improvement in sexual life
Description
Define the change in quality of sexual life after the used procedures by Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12)
Time Frame
36 month
Title
Improvement in pelvic floor symphtoms
Description
Define the change in quality of life after the used procedures by Pelvic Floor Distress Inventory (PFDI-20)
Time Frame
3 years follow up
Title
Improvement in quality of life
Description
Define the change in quality of life after the used procedures by urogenital distress inventory (UDI-6)
Time Frame
3 years
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
45 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Coexisting SUI and POP Q St II-III and signature of the informed consent
Exclusion Criteria:
Urge, mixed or neurogenic incontinency, occult SUI, previous mesh operations, antidepressive medical therapy, cancer of the pelvic organs, urinary infections, any sign of voiding difficulties
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Zoltán Fekete, M.D.
Phone
36209724158
Email
zoltan.fekete@freemail.hu
First Name & Middle Initial & Last Name or Official Title & Degree
Gábor Németh, M.D., PhD
Phone
3662545499
Email
nemethgdr@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Zoltan Fekete, M.D.
Organizational Affiliation
Szeged University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Gábor Németh, M.D., Ph.D.
Organizational Affiliation
Szeged University
Official's Role
Study Director
Facility Information:
Facility Name
Univ. of Szeged. Dep. of Obstetrics and Gynaecology
City
Szeged
ZIP/Postal Code
6720
Country
Hungary
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Fekete Zoltan, M.D.
Phone
209724158
Email
zoltan.fekete@med.u-szeged.hu
12. IPD Sharing Statement
Plan to Share IPD
Yes
Citations:
PubMed Identifier
18238969
Citation
Minassian VA, Stewart WF, Wood GC. Urinary incontinence in women: variation in prevalence estimates and risk factors. Obstet Gynecol. 2008 Feb;111(2 Pt 1):324-31. doi: 10.1097/01.AOG.0000267220.48987.17.
Results Reference
background
PubMed Identifier
24171152
Citation
Kirss F, Lang K, Toompere K, Veerus P. Prevalence and risk factors of urinary incontinence among Estonian postmenopausal women. Springerplus. 2013 Oct 17;2:524. doi: 10.1186/2193-1801-2-524. eCollection 2013.
Results Reference
background
PubMed Identifier
26638154
Citation
Akkus Y, Pinar G. Evaluation of the prevalence, type, severity, and risk factors of urinary incontinence and its impact on quality of life among women in Turkey. Int Urogynecol J. 2016 Jun;27(6):887-93. doi: 10.1007/s00192-015-2904-5. Epub 2015 Dec 5.
Results Reference
background
PubMed Identifier
19629013
Citation
Tinelli A, Malvasi A, Rahimi S, Negro R, Vergara D, Martignago R, Pellegrino M, Cavallotti C. Age-related pelvic floor modifications and prolapse risk factors in postmenopausal women. Menopause. 2010 Jan-Feb;17(1):204-12. doi: 10.1097/gme.0b013e3181b0c2ae.
Results Reference
background
PubMed Identifier
2333037
Citation
Molander U, Milsom I, Ekelund P, Mellstrom D. An epidemiological study of urinary incontinence and related urogenital symptoms in elderly women. Maturitas. 1990 Apr;12(1):51-60. doi: 10.1016/0378-5122(90)90060-j.
Results Reference
background
PubMed Identifier
26156205
Citation
Lau HH, Huang WC, Cheng YW, Wang H, Su TH. Changes in urodynamic measurements and bladder neck position after single-incision trans-vaginal mesh for pelvic organ prolapse. Int Urogynecol J. 2015 Nov;26(11):1629-35. doi: 10.1007/s00192-015-2753-2. Epub 2015 Jul 10.
Results Reference
background
PubMed Identifier
19643459
Citation
Sergent F, Gay-Crosier G, Bisson V, Resch B, Verspyck E, Marpeau L. Ineffectiveness of associating a suburethral tape to a transobturator mesh for cystocele correction on concomitant stress urinary incontinence. Urology. 2009 Oct;74(4):765-70. doi: 10.1016/j.urology.2009.05.038. Epub 2009 Jul 30.
Results Reference
background
PubMed Identifier
29282115
Citation
Fekete Z, Suranyi A, Renes L, Nemeth G, Kozinszky Z. Efficacy of anchoring the four-arm transvaginal mesh to the mid-urethra vs original surgery as a surgical correction for stress urine incontinence in coexisting anterior vaginal prolapse grades II and III: study protocol for a randomized controlled trial. Trials. 2017 Dec 28;18(1):624. doi: 10.1186/s13063-017-2314-8.
Results Reference
derived
Links:
URL
http://www.aspide.com/en/gynecological-urological-surgery/p/surgimesh-prolapse
Description
Surge-Mesh Prolapse by Aspide is used for both TVM method
Learn more about this trial
A Study on the Anti-incontinent Effectiveness of the mTVM Method in POPQ Stage II-III Patients
We'll reach out to this number within 24 hrs